Atrial fibrillation and COVID-19: An expert’s insights
06 Dec 2024
COVID-19 infection is not a simple respiratory illness. The damage set off by the virus is systemic, affecting not only the lungs but multiple organs, including the heart. At a Pfizer-sponsored symposium held at AFCC 2024 in Singapore, Dr William Kristanto, cardiologist at Cardiac Care Partners, Mount Elizabeth Medical Centre, Singapore, talked about atrial fibrillation and COVID-19, including the use of oral antiviral nirmatrelvir/ritonavir in adults at high risk for severe disease.
Resources
Atrial fibrillation and COVID-19: An expert’s insights
Atrial fibrillation and COVID-19: An expert’s insights